A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Conditions: Essential Hypertension; Primary Hypercholesterolemia Interventions: Drug: Fimasartan; Drug: Ezetimibe/Atorvastatin; Drug: Fimasartan Placebo; Drug: Ezetimibe/Atorvastatin Placebo Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | Hypertension | Lipitor | Research | Statin Therapy | Study | Vytorin | Zetia | Zivast